IFNG and neoplasm: Addition of the TGFβRII inhibitor SB431542 to OT-I:ID8-OVA-T4 co-cultures doubled the proportions of IFNγ+granzyme B+ OT-I cells, but did not impact upon OT-I T cell responses to ID8-OVA-N4 tumour cells.